Skip to main content
. 2019 Oct 4;12:8217–8227. doi: 10.2147/OTT.S217468

Figure 5.

Figure 5

Angiogenesis was promoted by sorafenib therapy in the xenograft mouse model, based on Western blot. The expression of VEGFR-1 and CD31 was observed by Western blot analysis (left panel) and associated statistical analysis (right panel) in Chang liver (A), PLC/PRF/5 (B), and HepG2 (C) xenograft tumors. *P<0.05, ***P<0.01 compared to control group.

Abbreviations: C, control group; S, sorafenib treated group.